64th ASH Annual Meeting and Exposition
December 10-13, 2022 | Come and see us in New Orleans, LA at the 64th American Society of Hematology Annual meeting and Exposition
News & Events
San Antonio Breast Cancer Symposium 2022
December 6-10, 2022 | Come and see us in San Antonio, TX at the San Antonio Breast Cancer Symposium
HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery
TUCSON, Ariz. , Oct. 12, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, completed its planned milestones for the third quarter of 2022, further…
- Category:
- Press Releases
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
TUCSON, Ariz. , Sept. 26, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate in the Cantor Fitzgerald…
- Category:
- Press Releases
The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test
TUCSON, Ariz. , Sept. 20, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that the Fundación Instituto Valenciano de Oncología, located in…
- Category:
- Press Releases
2022 European Association for Haematopathology (EAHP) Congress
SEPTEMBER 17-21, 2022 | Join us at the 2022 European Association for Haematopathology (EAHP) Congress in Florence, Italy
- Category:
- Past Events
- Molecular
HTG Molecular Diagnostics Reports Second Quarter 2022 Results
Call scheduled for today, August 11, 2022, at 4:30 pm ET TUCSON, Ariz. , Aug. 11, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent…
- Category:
- Press Releases
HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11
TUCSON, Ariz. , Aug. 04, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended…
- Category:
- Press Releases
12th Annual World Clinical Biomarkers and CDx Summit
SEPTEMBER 28-29, 2022 | Join us at the 12th Annual World Clinical Biomarkers and CDx Summit in Boston, MA
HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition
TUCSON, Ariz. , July 19, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will host a key opinion leader (KOL) webinar on “ Drug…
- Category:
- Press Releases
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
TUCSON, Ariz. , July 18, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced it has entered into an amendment of its June 24, 2020 Loan and…
- Category:
- Press Releases
HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery
TUCSON, Ariz. , July 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper (the “White Paper”), further establishing the…
- Category:
- Press Releases
Page last updated March 20, 2023